Below are the financial statements of Biomerieux, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of EUR | 2024 | 2023 |
|---|---|---|
| Revenue | 3,979.9a | 3,674.7a |
| Cost of sales | -1,764.6a | -1,617.4a |
| Gross profit | 2,215.3a | 2,057.3a |
| Other operating income and expenses | 46.9a | 33a |
| Selling and marketing expenses | -783.8a | -725.5a |
| General and administrative expenses | -313.8a | -295a |
| Research and development | -491.5a | -460.1a |
| Total operating expenses | -1,589.1a | -1,480.7a |
| Amortization and impairment of intangible assets related to acquisitions and acquisition-related costs | -58.4a | -170.6a |
| Operating income before non-recurring items | 614.7a | 439a |
| Other non-recurring income and expenses from operations | -25.9a | 0a |
| Operating income | 588.8a | 439a |
| Cost of net financial debt | -4.9a | -1.4a |
| Other financial income and expenses | -4.5a | -3.1a |
| Income tax | -154.3a | -114.5a |
| Share in net income of associates | 0a | 0a |
| Consolidated net income | 425.1a | 322.8a |
| Share attributable to non-controlling interests | -7.1a | -34.8a |
| Attributable to the parent company | 432.2a | 357.6a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biomerieux’s data sources below and access millions more through our Disclosure Search.